Delivery Order SPE2DR25D1017-SPE2DR26F9CDK
- Not listed
- The Defense Logistics Agency awarded a $10,623.31 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $13,410.70 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,707.30 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance at the contractor's Conshohocken, Pennsylvania facility. This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 28, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this...
- The Defense Logistics Agency awarded a $37,568.01 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 30, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $18,171.41 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector medication. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $29,995.79 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,017.61 on November 5, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract utilizes firm fixed pricing with no set-aside designation and is expected to be completed by November 6, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated...
- The Defense Logistics Agency awarded a $64,840.72 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance at the contractor's Conshohocken, Pennsylvania facility. This non-competitive, firm fixed-price delivery order was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025. The award represents a child delivery order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $33,388.01 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance completion by December 2, 2025. This non-set-aside, firm fixed-price delivery order was issued on December 1, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $15,827.33 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion deadline of December 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CDKDelivery Order
The Defense Logistics Agency awarded a $12,650.84 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, and an ultimate completion date of December 30, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that serves as the primary vehicle for global pharmaceutical support to U.S. military healthcare systems. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, regularly fulfills federal medical procurement requirements through competitive awards with the DLA and its Medical Supply Chain. The company supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Repatha—a PCSK9 inhibitor used for cholesterol management—demonstrates the contractor's role in providing specialized cardiovascular medications to support Defense Health Agency medical programs and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 12/28/25 |